| Cash Flow | 2025-09-06 | 2025-06-14 | 2025-03-22 | 2024-09-07 |
|---|---|---|---|---|
| Net income | 5,740 | 3,122 | 1,843 | 8,092 |
| Depreciation and amortization | 2,315 | 1,491 | 684 | 2,118 |
| Impairment and other (credits)/charges | - | - | - | 10 |
| Impairment and other charges | 1,960 | 1,860 | - | - |
| Product recall-related impact | 0 | 0 | 0 | 184 |
| Payments for product recall-related impact | 5 | 2 | 2 | 138 |
| Operating lease right-of-use asset amortization | 489 | 315 | 145 | 438 |
| Share-based compensation expense | 207 | 131 | 77 | 260 |
| Restructuring and impairment charges | 567 | 426 | 213 | 415 |
| Cash payments for restructuring charges | 554 | 387 | 232 | 284 |
| Business combination, separately recognized transactions, net gains and losses | -308 | - | - | - |
| Payments for merger related costs | 80 | - | - | - |
| Pension and retiree medical plan expenses | 164 | 99 | 48 | 114 |
| Pension and retiree medical plan contributions | 400 | 354 | 317 | 300 |
| Deferred income taxes and other tax charges and credits | 30 | -260 | 111 | 124 |
| Tax payments related to the tax cuts and jobs act (tcj act) | 772 | 772 | - | 579 |
| Accounts and notes receivable | 1,747 | 1,582 | 318 | 1,521 |
| Inventories | 449 | 800 | 238 | 492 |
| Prepaid expenses and other current assets | 223 | 354 | 307 | 200 |
| Accounts payable and other current liabilities | -1,647 | -2,083 | -2,671 | -2,312 |
| Income taxes payable | 6 | 415 | 223 | 426 |
| Other, net | -441 | -269 | -232 | -135 |
| Net cash provided by operating activities | 5,468 | 996 | -973 | 6,220 |
| Capital spending | 2,499 | 1,507 | 603 | 2,850 |
| Sales of property, plant and equipment | 272 | 169 | 132 | 177 |
| Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets | 3,176 | 3,130 | 1,200 | 31 |
| Divestitures, sales of investments in noncontrolled affiliates and other assets | 5 | 5 | 2 | 145 |
| Payments to acquire short-term investments | 190 | - | - | 425 |
| More than three months - maturities | 425 | 425 | 425 | 0 |
| Proceeds from sale of debt securities, available-for-sale | - | - | - | 0 |
| Payments for (proceeds from) short-term investments, three months or less, net | -43 | -22 | -16 | -4 |
| Other investing, net | 117 | 111 | 4 | -15 |
| Net cash used for investing activities | -5,237 | -4,127 | -1,232 | -2,965 |
| Proceeds from issuances of long-term debt | 8,179 | 3,521 | 3,505 | 4,014 |
| Payments of long-term debt | 3,245 | 2,543 | 1,541 | 2,883 |
| More than three months - proceeds | 5,528 | 5,251 | 3,656 | 3,808 |
| More than three months - payments | 5,417 | 2,492 | 2,119 | 4,177 |
| Three months or less, net | 445 | 2,438 | 373 | 101 |
| Cash dividends paid | 5,692 | 3,743 | 1,882 | 5,369 |
| Share repurchases | 752 | 494 | 183 | 760 |
| Proceeds from exercises of stock options | 76 | 58 | 50 | 138 |
| Withholding tax payments on restricted stock units (rsus) and performance stock units (psus) converted | 112 | 111 | 89 | 132 |
| Other financing | -18 | -17 | -2 | -22 |
| Net cash used for financing activities | -1,008 | 1,868 | 1,768 | -5,282 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | 395 | 422 | 203 | -391 |
| Net decrease in cash and cash equivalents and restricted cash | -382 | -841 | -234 | -2,418 |
| Cash and cash equivalents at beginning of period | 8,553 | 8,553 | 8,553 | 9,761 |
| Cash and cash equivalents at end of period | 8,171 | 7,712 | 8,319 | 7,343 |
PEPSICO INC (PEP)
PEPSICO INC (PEP)